Search

Joseph A Kaufman

Examiner (ID: 10129)

Most Active Art Unit
3754
Art Unit(s)
3752, 3993, 3727, 3754, 3108, 3104
Total Applications
1964
Issued Applications
1543
Pending Applications
181
Abandoned Applications
196

Applications

Application numberTitle of the applicationFiling DateStatus
Array ( [id] => 7545261 [patent_doc_number] => 08053232 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2011-11-08 [patent_title] => 'Correction of alpha-1-antitrypsin genetic defects using spliceosome mediated RNA trans splicing' [patent_app_type] => utility [patent_app_number] => 11/040634 [patent_app_country] => US [patent_app_date] => 2005-01-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 9 [patent_no_of_words] => 13335 [patent_no_of_claims] => 24 [patent_no_of_ind_claims] => 16 [patent_words_short_claim] => 110 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/08/053/08053232.pdf [firstpage_image] =>[orig_patent_app_number] => 11040634 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/040634
Correction of alpha-1-antitrypsin genetic defects using spliceosome mediated RNA trans splicing Jan 20, 2005 Issued
Array ( [id] => 5672578 [patent_doc_number] => 20060177933 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-08-10 [patent_title] => 'Expression of apoA-1 and variants thereof using spliceosome mediated RNA trans-splicing' [patent_app_type] => utility [patent_app_number] => 11/041155 [patent_app_country] => US [patent_app_date] => 2005-01-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 44 [patent_figures_cnt] => 44 [patent_no_of_words] => 15621 [patent_no_of_claims] => 156 [patent_no_of_ind_claims] => 44 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0177/20060177933.pdf [firstpage_image] =>[orig_patent_app_number] => 11041155 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/041155
Expression of apoA-1 and variants thereof using spliceosome mediated RNA trans-splicing Jan 20, 2005 Abandoned
Array ( [id] => 5219799 [patent_doc_number] => 20070161110 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-07-12 [patent_title] => 'Methods for producing minus-strand rna viral vectors using hybrid promoter comprising cytomegalovirus enhancer and chicken beta-actin promoter' [patent_app_type] => utility [patent_app_number] => 10/586142 [patent_app_country] => US [patent_app_date] => 2005-01-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 22 [patent_figures_cnt] => 22 [patent_no_of_words] => 24998 [patent_no_of_claims] => 28 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0161/20070161110.pdf [firstpage_image] =>[orig_patent_app_number] => 10586142 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/586142
Methods for producing minus-strand RNA viral vectors using hybrid promoter comprising cytomegalovirus enhancer and chicken β-actin promoter Jan 19, 2005 Issued
Array ( [id] => 6977404 [patent_doc_number] => 20050287120 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-12-29 [patent_title] => 'Cancer - targeted viral vectors' [patent_app_type] => utility [patent_app_number] => 11/032757 [patent_app_country] => US [patent_app_date] => 2005-01-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 8 [patent_no_of_words] => 7710 [patent_no_of_claims] => 28 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0287/20050287120.pdf [firstpage_image] =>[orig_patent_app_number] => 11032757 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/032757
Cancer - targeted viral vectors Jan 10, 2005 Abandoned
Array ( [id] => 4772586 [patent_doc_number] => 20080058245 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-03-06 [patent_title] => 'Vectors for Recombinant Protein Expression in E. Coli' [patent_app_type] => utility [patent_app_number] => 10/585440 [patent_app_country] => US [patent_app_date] => 2005-01-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 23 [patent_figures_cnt] => 23 [patent_no_of_words] => 18092 [patent_no_of_claims] => 35 [patent_no_of_ind_claims] => 24 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0058/20080058245.pdf [firstpage_image] =>[orig_patent_app_number] => 10585440 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/585440
Vectors for Recombinant Protein Expression in E. Coli Jan 5, 2005 Abandoned
Array ( [id] => 7039339 [patent_doc_number] => 20050158773 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-07-21 [patent_title] => 'Direct identification and mapping of RNA transcripts' [patent_app_type] => utility [patent_app_number] => 11/022102 [patent_app_country] => US [patent_app_date] => 2004-12-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 7536 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0158/20050158773.pdf [firstpage_image] =>[orig_patent_app_number] => 11022102 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/022102
Direct identification and mapping of RNA transcripts Dec 22, 2004 Abandoned
Array ( [id] => 7045601 [patent_doc_number] => 20050250196 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-11-10 [patent_title] => 'Recombinant microorganisms expressing an oligosaccharide receptor mimic' [patent_app_type] => utility [patent_app_number] => 11/018745 [patent_app_country] => US [patent_app_date] => 2004-12-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 25282 [patent_no_of_claims] => 47 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0250/20050250196.pdf [firstpage_image] =>[orig_patent_app_number] => 11018745 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/018745
Recombinant microorganisms expressing an oligosaccharide receptor mimic Dec 19, 2004 Abandoned
Array ( [id] => 8016917 [patent_doc_number] => 08137960 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2012-03-20 [patent_title] => 'Bovine adeno-associated viral (BAAV) vector and uses thereof' [patent_app_type] => utility [patent_app_number] => 10/581228 [patent_app_country] => US [patent_app_date] => 2004-12-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 34 [patent_figures_cnt] => 21 [patent_no_of_words] => 35326 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 65 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/08/137/08137960.pdf [firstpage_image] =>[orig_patent_app_number] => 10581228 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/581228
Bovine adeno-associated viral (BAAV) vector and uses thereof Dec 5, 2004 Issued
Array ( [id] => 8317085 [patent_doc_number] => 08231861 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2012-07-31 [patent_title] => 'Pancreatitis' [patent_app_type] => utility [patent_app_number] => 10/579865 [patent_app_country] => US [patent_app_date] => 2004-11-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 18 [patent_no_of_words] => 7538 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 74 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 10579865 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/579865
Pancreatitis Nov 18, 2004 Issued
Array ( [id] => 533577 [patent_doc_number] => 07176029 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2007-02-13 [patent_title] => 'Cloning and/or sequencing vector' [patent_app_type] => utility [patent_app_number] => 10/994208 [patent_app_country] => US [patent_app_date] => 2004-11-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 4506 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 57 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/176/07176029.pdf [firstpage_image] =>[orig_patent_app_number] => 10994208 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/994208
Cloning and/or sequencing vector Nov 18, 2004 Issued
Array ( [id] => 6912307 [patent_doc_number] => 20050176065 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-08-11 [patent_title] => 'Target sequences for synthetic molecules' [patent_app_type] => utility [patent_app_number] => 10/970635 [patent_app_country] => US [patent_app_date] => 2004-10-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 19 [patent_figures_cnt] => 19 [patent_no_of_words] => 14324 [patent_no_of_claims] => 43 [patent_no_of_ind_claims] => 8 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0176/20050176065.pdf [firstpage_image] =>[orig_patent_app_number] => 10970635 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/970635
Target sequences for synthetic molecules Oct 21, 2004 Abandoned
Array ( [id] => 6905495 [patent_doc_number] => 20050100890 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-05-12 [patent_title] => 'Methods for producing and using in vivo pseudotyped retroviruses' [patent_app_type] => utility [patent_app_number] => 10/964574 [patent_app_country] => US [patent_app_date] => 2004-10-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 15629 [patent_no_of_claims] => 23 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0100/20050100890.pdf [firstpage_image] =>[orig_patent_app_number] => 10964574 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/964574
Methods for producing and using in vivo pseudotyped retroviruses Oct 12, 2004 Abandoned
Array ( [id] => 6905547 [patent_doc_number] => 20050100942 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-05-12 [patent_title] => 'Nucleic acid sequences and methods for identifying compounds that affect RNA/RNA binding protein interactions and mRNA functionality' [patent_app_type] => utility [patent_app_number] => 10/963062 [patent_app_country] => US [patent_app_date] => 2004-10-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 6701 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0100/20050100942.pdf [firstpage_image] =>[orig_patent_app_number] => 10963062 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/963062
Nucleic acid sequences and methods for identifying compounds that affect RNA/RNA binding protein interactions and mRNA functionality Oct 11, 2004 Abandoned
Array ( [id] => 7965237 [patent_doc_number] => 07939266 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2011-05-10 [patent_title] => 'Treatment of transformed or infected biological cells' [patent_app_type] => utility [patent_app_number] => 10/961320 [patent_app_country] => US [patent_app_date] => 2004-10-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 9606 [patent_no_of_claims] => 5 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 128 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/939/07939266.pdf [firstpage_image] =>[orig_patent_app_number] => 10961320 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/961320
Treatment of transformed or infected biological cells Oct 7, 2004 Issued
Array ( [id] => 5199705 [patent_doc_number] => 20070299023 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-12-27 [patent_title] => 'P185Neu-Encoding Dna and Therapeutical Uses Thereof' [patent_app_type] => utility [patent_app_number] => 10/574897 [patent_app_country] => US [patent_app_date] => 2004-10-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 15 [patent_figures_cnt] => 15 [patent_no_of_words] => 5959 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0299/20070299023.pdf [firstpage_image] =>[orig_patent_app_number] => 10574897 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/574897
P185 Neu-encoding DNA and therapeutical uses thereof Oct 5, 2004 Issued
Array ( [id] => 5071778 [patent_doc_number] => 20070192880 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-08-16 [patent_title] => 'Horming response element binding transregulators' [patent_app_type] => utility [patent_app_number] => 10/574322 [patent_app_country] => US [patent_app_date] => 2004-10-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 12 [patent_figures_cnt] => 12 [patent_no_of_words] => 55915 [patent_no_of_claims] => 67 [patent_no_of_ind_claims] => 15 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0192/20070192880.pdf [firstpage_image] =>[orig_patent_app_number] => 10574322 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/574322
Horming response element binding transregulators Oct 3, 2004 Abandoned
Array ( [id] => 7161027 [patent_doc_number] => 20050084844 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-04-21 [patent_title] => 'Genetic screen for bioactive peptides' [patent_app_type] => utility [patent_app_number] => 10/953658 [patent_app_country] => US [patent_app_date] => 2004-09-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 11839 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0084/20050084844.pdf [firstpage_image] =>[orig_patent_app_number] => 10953658 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/953658
Genetic screen for bioactive peptides Sep 28, 2004 Issued
10/491707 Methods for identifying agents that prevent palindrome formation and gene amplification in mammalian cells Sep 26, 2004 Abandoned
Array ( [id] => 5828213 [patent_doc_number] => 20060063259 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-03-23 [patent_title] => 'Production of adenovirus vectors with reduced levels of replication competent adenovirus contamination' [patent_app_type] => utility [patent_app_number] => 10/946484 [patent_app_country] => US [patent_app_date] => 2004-09-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 36 [patent_figures_cnt] => 36 [patent_no_of_words] => 21855 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0063/20060063259.pdf [firstpage_image] =>[orig_patent_app_number] => 10946484 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/946484
Production of adenovirus vectors with reduced levels of replication competent adenovirus contamination Sep 20, 2004 Issued
Array ( [id] => 6917670 [patent_doc_number] => 20050095231 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-05-05 [patent_title] => 'Modified adenovirus containing a fiber replacement protein' [patent_app_type] => utility [patent_app_number] => 10/944496 [patent_app_country] => US [patent_app_date] => 2004-09-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 16 [patent_figures_cnt] => 16 [patent_no_of_words] => 21022 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0095/20050095231.pdf [firstpage_image] =>[orig_patent_app_number] => 10944496 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/944496
Modified adenovirus containing a fiber replacement protein Sep 16, 2004 Abandoned
Menu